疑似脓毒症中不必要的快速抗生素给药电子临床监测指标的开发
研究基于12家医院急诊科的113764例疑似脓毒症成人患者,构建了电子健康记录数据衍生的脓毒症过度治疗监测指标(SEP-OS),定义为快速静脉抗生素给药(≤3小时)但最终不符合CDC成人脓毒症事件「真脓毒症」定义的患者比例。结果显示过度治疗患病率为22.5%,该指标满足预设的信度、内容效度、结构效度和效标效度标准,且过度治疗组抗生素使用天数、住院时长、院内死亡率及出院后6个月内艰难梭菌感染频率均高于真阴性组。
要点
- SEP-OS指标定义:快速静脉抗生素(≤3小时)但不符合CDC真脓毒症定义的患者比例。
- 在113764例疑似脓毒症成人中,脓毒症过度治疗患病率为22.5%。
- 过度治疗组抗生素天数4天 vs 真阴性组1天,住院时长4天 vs 3天,院内死亡率2.4% vs 2.1%,艰难梭菌感染频率更高。
核心结论
- 研究开发了一种新颖、有效的电子健康记录指标,用于脓毒症过度治疗的临床监测;应用于大型疑似脓毒症患者队列显示过度治疗率高,为脓毒症质量改进目标提供了有用工具。
研究设计与样本
- 评估12家医院急诊科就诊的潜在脓毒症成人患者(到达6小时内满足≥2项全身炎症反应综合征标准),排除休克患者。
主要发现
- 在113764例 eligible 患者中,脓毒症过度治疗患病率为22.5%。
- 过度治疗标准分类的患者中位抗生素天数4天(IQR 2-5) vs 真阴性组1天(IQR 1-2),P < .01。
- 过度治疗标准分类的患者中位住院时长4天(IQR 2-6) vs 真阴性组3天(IQR 2-5),P < .01。
- 过度治疗标准分类的患者院内死亡率2.4% vs 真阴性组2.1%,P = .01。
- 过度治疗标准分类的患者出院后6个月内艰难梭菌感染频率高于真阴性组,P < .01。
关键数值与推荐
- SEP-OS定义为接受快速静脉抗生素(≤3小时)但最终不符合CDC成人脓毒症事件「真脓毒症」定义的患者比例。
- 该指标满足预设的信度、内容效度、结构效度和效标效度标准。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Substantial efforts focus on monitoring and reducing delays in antibiotic treatment for sepsis, but little has been done to characterize the balancing measure of sepsis overtreatment. We aimed to establish preliminary validity and usefulness of electronic health record (EHR) data-derived criteria for sepsis overtreatment surveillance (SEP-OS). METHODS: We evaluated adults with potential sepsis (≥2 Systemic Inflammatory Response Syndrome criteria within 6 hours of arrival) presenting to the emergency department of 12 hospitals, excluding patients with shock. We defined SEP-OS as the proportion of patients receiving rapid IV antibiotics (≤3 hours) who did not ultimately meet the Centers for Disease Control Adult Sepsis Event "true sepsis" definition. We evaluated the frequency and characteristics of patients meeting overtreatment criteria and outcomes associated with sepsis overtreatment. RESULTS: Of 113 764 eligible patients, the prevalence of sepsis overtreatment was 22.5%. The measure met prespecified criteria for reliability, content, construct, and criterion validity. Patients classified by the SEP-OS overtreatment criteria had higher median antibiotic days (4 days [IQR, 2-5] vs 1 day [1-2]; P < .01), longer median length of stay (4 days [2-6] vs 3 days [2-5]; P < .01), higher hospital mortality (2.4% vs 2.1%; P = .01), and higher frequency of Clostridioides difficile infection within 6 months of hospital discharge (P < .01) compared with "true negative" cases. CONCLUSIONS: We developed a novel, valid EHR metric for clinical surveillance of sepsis overtreatment. Applying this metric to a large cohort of potential sepsis patients revealed a high rate of overtreatment and provides a useful tool to inform sepsis quality-improvement targets.
引用
- Taylor SP, Palakshappa JA, Chou SH, et al. Development of an Electronic Clinical Surveillance Measure for Unnecessary Rapid Antibiotic Administration in Suspected Sepsis. Clin Infect Dis. 2025. PMID: 39360843. doi:10.1093/cid/ciae445
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。